medigraphic.com
ISSN 1561-3186 (Electronic)

2014, Number 1

<< Back Next >>

Rev Acta Médica 2014; 15 (1)

La hiperglucemia como marcador pronóstico durante los eventos coronarios y cerebro vasculares agudos

Buchaca FEF, Arbona MY, Gutiérrez RÁR, Rodríguez AL, Fernández VF, Bermúdez RS

Language: Spanish
References: 45
Page:
PDF size: 245.06 Kb.


ABSTRACT

No abstract.


REFERENCES

  1. Kosiborok M, Rathore SS, Inzucchi SE, Masoudi FA, Wang Y, Havranek EP, et al. Admission glucose and mortality patients hospitalized with acute myocardial infarction: implications for patients with and without recognized diabetes. Circulation 2005;111(23);3078-86.

  2. Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, et al. Intensive insulin therapy in critically ill patients. N Engl J Med 2001 345(19);1359- 67.

  3. Van den Berghe G, Wilmer A, Hermans G, Meersseman W, Wouters PJ, Milants I, et al. Intensive insulin therapy in the medical ICU.N Engl J Med 2006; 354(5):449-61.

  4. Van den Berghe G, Wilmer A, Milants I, Wouters PJ, Bouckaert B, Bruyninckx F, et al. Intensive insulin therapy in mixed medical /surgical intensive care units: benefits versus harm. Diabetes 2006; 55(11):3151-9.

  5. Parsons MW, Barber PA, Desmond PM, Baird TA, Darby DG, Byrnes G, et al. Acute hyperglycemia adversely affects stroke outcome: a magnetic resonance imaging and spectroscopy study. Ann Neurol 2002; 52 (1):20-8.

  6. Gray CS. The United Kingdom Glucose Insulin in Stroke Trial (GIST-UK). Stroke 2002; 33:2525-35.

  7. Walters MR, Weir CJ, Lees KR. A randomised, controlled pilot study to investigate the potential benefit of intervention with insulin in hyperglycaemic acute ischaemic stroke patients. Cerebrovasc Dis 2006; 22:116-22.

  8. Garg R, Chaudhuri A, Munschauer F, Dandona P. Hyperglycemia, insulin, and acute ischemic stroke: a mechanistic justification for a trial of insulin infusion therapy. Stroke 2006; 37:267-73.

  9. Stranders I, Diaman M, E. Van Gelde R. Spruijt H, W. R. Twisk J, Heine R, et al. Admission Blood Glucose Level as Risk Indicator of Death After Myocardial Infarction in Patients With and Without Diabetes Mellitus. Arch Intern Med. 2004; 164(9):982-8.

  10. Sinnaeve P, Steg P, Fox K, Van de Werf F, Montalescot G, Granger C, et al; for the GRACE Investigators. Association of Elevated Fasting Glucose with Increased Shortterm and 6-Month Mortality in ST-Segment Elevation and Non-ST-Segment Elevation Acute Coronary Syndromes. The Global Registry of Acute Coronary Events. Arch Intern Med 2009; 169(4):402-9.

  11. Hanefeld M, Fischer S, Julius U, et al. Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up. Diabetologia. 1996; 39:1577-83.

  12. Levitan E, Song Y, Ford E, Liu S. Is Nondiabetic Hyperglycemia a Risk Factor for Cardiovascular Disease? A Meta-analysis of Prospective Studies. Arch Intern Med. 2004; 164:2147-55.

  13. Kiers L, Davis SM, Larkins R, et al. Stroke topography and outcome in relation to hyperglycemia and diabetes. J Neurol Neurosurg Psychiatry 1992; 55: 263-270.

  14. Parsons MW, Barber PA, Desmond PM, et al. Acute hyperglycemia adversely affects stroke outcome: a magnetic resonance imaging and spectroscopy study. Ann Neurol 2002; 52: 20-28.

  15. Kimura K, Sakamoto Y, Iguchi Y, et al. Admission hyperglycemia and serial infarct volume after t-PA therapy in patients with and without early recanalization. J Neurol Sci 2011; 307: 55-59.

  16. Inzucchi SE, Siegel M. Glucose control in the ICU-How tight is too tight? N Engl J Med 2009; 360:1346-9.

  17. Buchaca Faxas EF, Castillo Carrillo FR, Rodríguez Amador L, Bermúdez Rojas S, Fernández Valdés F, Gutiérrez Rojas AR. Hiperglucemia como indicador pronóstico durante los eventos macrovasculares agudos. Av. Diabetol 2012; 28(2):48-54

  18. Valdés Ramos ER, Rivera Chávez M, Bencosme Rodríguez N. Comportamiento del infarto agudo del miocardio en personas con diabetes mellitus de la provincia Granma. Rev Cubana Endocrinol 2012;23(2):128-13.

  19. AACE Diabetes Mellitus Clinical Practice Guidelines Task Force. Endocrine Practice 2007; 13(1):3-68.

  20. López BL, Fernández OA, Bueno ZH, Coma CI, Lidon CRM, Cequier FA, et al. Guías de práctica clínica de la Sociedad Española de Cardiología en la angina inestable/infarto sin elevación ST. Rev Esp Cardiol 2000; 53: 838-50.

  21. Thygesen K, Alpert JS, White HD. Universal definition of myocardial infarction. Task Force for the redefinition of myocardial infarction. ESC/ACCF/AHA/WHF. Eur Heart J. 2007; 28:2525-38.

  22. Braunwald E. Unstable angina. A classification. Circulation 1989; 80:410-4.

  23. Rodríguez FE y Viñolas PX. Causas de muerte súbita. Problemas a la hora de establecer y clasificar los tipos de muerte. Rev Esp Cardiol 1999; 52: 1004-101.

  24. Adams HP Jr, Adams RJ, Brott T, del Zoppo GJ, Furlan A, Goldstein CB, et al: Guidelines for the early management of patients with ischemic stroke: A scientific statement from the Stroke Council of the American Stroke Association. Stroke 2003; 34(4):1056-83.

  25. Brown DL, Morgenstern LB: Stopping the bleeding in intracerebral hemorrhage. N Engl J Med. 2005; 352(8):828-30.

  26. Chalela JA, Kidwell CS, Nentwich LM, Luby M, Butman JA, Demchuk AM, et al. Magnetic resonance imaging and computed tomography in emergency assessment of patients with suspected acute stroke: a prospective comparison. Lancet. 2007; 369:293-8.

  27. Edlow JA, Caplan LR. Avoiding pitfalls in the diagnosis of subarachnoid hemorrhage. N Engl J Med 2000; 342:29-36.

  28. Arós F, Loma OA, Alonso A, Alonso JJ, Cabadés A, Coma CI, et al. Guías de actuación clínica de la Sociedad Española de Cardiología en el infarto agudo de miocardio. Rev Esp Cardiol 1999; 52: 919-56.

  29. Maki DG, Weinstein RA. Nosocomial infection in the intensive care unit, in Critical Care Medicine. En: Parillo JE, Dellinger, editores. Principles of Diagnosis and Management in the Adult. 2d ed. Philadelphia: Saunders 2001; p 981-1046.

  30. Bederson JB, Awad IA, Wiebers DO, Piepgras D, Haley EC Jr, Brott T, et al: Recommendations for the management of patients with unruptured intracranial aneurysms: A statement for healthcare professionals from the Stroke Council, American Heart Association. Stroke 2000; 31(11):2742-50.

  31. Goyal A, Mahaffey KW, Garg J, Nicolau JC, Hochman JS, Weaver WD, et al. Prognostic significance of the change in glucose level in the first 24 h after acute myocardial infarction: results from the CARDINAL study. Eur Heart J. 2006; 27(11):1289-97.

  32. Malmberg K, Norhammar A, Wedel H. Glycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: long-term results from the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) Study. Circulation 1999; 25: 2626-32.

  33. Leonidou L, Mouzaki A, Michalaki M, DeLastic AL, Kyriazopoulou V, Bassaris HP, Gogos CA: Cytokine production and hospital mortality in patients with sepsis-induced stress hyperglycemia. J Infect 2007, 55:340-6.

  34. Merz Tobias and Finfer Simon. Pro/con debate: Is intensive insulin therapy targeting tight blood glucose control of benefit in critically ill patients? Critical Care 2008, 12:212.

  35. Kosiborod Mikhail, Inzucchi SE, Krumholz HM, Masoudi FA, Goyal A, Xiao L, et al. Glucose Normalization and Outcomes in Patients With Acute Myocardial Infarction. Arch Intern Med. 2009; 169(5):438-46.

  36. Cavalot F, Petrelli A, Traversa M, Bonomo K, Fiora E, Conti M, et al. Postprandial blood glucose is a stronger predictor of cardiovascular events than fasting blood glucose in type 2 diabetes mellitus, particularly in women: lessons from the San Luigi Gonzaga Diabetes Study. J Clin Endocrinol Metab. 2006; 91(3):813-9.

  37. Breuer H. The postprandial blood glucose level. Eur H Journal 2000; 2(suppl D):D36-8.

  38. Nicolau JC, Serrano jr CV, Giraldez RR, Baracioli LM, Moreira HG, Lima F, et al. In Patients With Acute Myocardial Infarction, the Impact of Hyperglycemia as a Risk Factor for Mortality Is Not Homogeneous Across Age-Groups. Diabetes Care 2012; 35:150-2.

  39. Fernández Concepción O, Buergo Zuaznábar MA, López Jiménez M. Hiperglicemia post-ictus. Rev Cubana Neurol Neurocir 2012; 2(2):144-9.

  40. Shimoyama T, Shibazaki K, Kimura K, Uemura J, Shiromoto T, Watanabe M, et al. Admission hyperglycemia causes infarct volume expansion in patients with ICA or MCA occlusion: association of collateral grade on conventional angiography. European Journal of Neurology, 20: 109-116. doi: 10.1111/j.1468-1331.2012.03801.x

  41. Stolker Jm, Spertus Ja, Mcguire Dk, Lind M, Tang F, Jones PG, et al. Relationship Between Glycosylated Hemoglobin Assessment and Glucose Therapy Intensification in Patients With Diabetes Hospitalized for Acute Myocardial Infarction. Diabetes Care 2012; 35:991-3.

  42. Ariesen M, Claus S, Rinkel G, Algra A. Risk factors for intracerebral hemorrhage in the general population: a systematic review. Stroke. 2003; 34:2060-5.

  43. Antman EM, Hand M, Armstrong PW, Bates ER, Green LA, Halasyamani LK, et al. 2008 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). J.Am Coll Cardiol 2008, 51 (2): 210-47.

  44. Li Jz, Chen Ml, Wang S, Dong J, Zeng P, Hou LW. A long-term follow-up study of serum lipid levels and coronary heart disease in the elderly. Chinese Medical Journal 2004; 117(2):163-7.

  45. Tanaka F, Makita S, Onoda T, Tanno K, Ohsawa M, Itai K, et al. Predic1. Kosiborok M, Rathore SS, Inzucchi SE, Masoudi FA, Wang Y, Havranek EP, et al. Admission glucose and mortality patients hospitalized with acute myocardial infarction: implications for patients with and without recognized diabetes. Circulation 2005;111(23);3078-86.




2020     |     www.medigraphic.com